Stericycle (NASDAQ:SRCL) Price Target Raised to $62.00 at Truist Financial

Stericycle (NASDAQ:SRCLFree Report) had its price objective boosted by Truist Financial from $50.00 to $62.00 in a report issued on Tuesday, Benzinga reports. Truist Financial currently has a hold rating on the business services provider’s stock.

A number of other brokerages also recently issued reports on SRCL. Wells Fargo & Company increased their price objective on shares of Stericycle from $40.00 to $48.00 and gave the stock an underweight rating in a research note on Friday, March 1st. Royal Bank of Canada reissued an outperform rating and issued a $69.00 price objective on shares of Stericycle in a research note on Thursday, March 7th. Stifel Nicolaus raised their target price on Stericycle from $70.00 to $75.00 and gave the company a buy rating in a report on Thursday, February 29th. Robert W. Baird lowered their price target on Stericycle from $62.00 to $55.00 and set a neutral rating for the company in a report on Friday, April 26th. Finally, StockNews.com downgraded Stericycle from a buy rating to a hold rating in a research report on Tuesday, April 2nd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of Hold and a consensus price target of $74.00.

View Our Latest Stock Analysis on SRCL

Stericycle Stock Performance

Shares of NASDAQ:SRCL opened at $59.11 on Tuesday. Stericycle has a 12-month low of $37.78 and a 12-month high of $59.45. The company’s 50 day moving average price is $49.10 and its two-hundred day moving average price is $49.39. The firm has a market cap of $5.48 billion, a PE ratio of -268.68, a PEG ratio of 2.78 and a beta of 1.08. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.55.

Stericycle (NASDAQ:SRCLGet Free Report) last posted its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. The firm had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company’s revenue was down 2.8% on a year-over-year basis. During the same quarter last year, the company earned $0.49 EPS. Equities research analysts predict that Stericycle will post 2.32 earnings per share for the current year.

Institutional Investors Weigh In On Stericycle

Hedge funds and other institutional investors have recently bought and sold shares of the company. Citigroup Inc. increased its position in Stericycle by 0.6% in the 3rd quarter. Citigroup Inc. now owns 46,953 shares of the business services provider’s stock valued at $2,099,000 after acquiring an additional 285 shares during the period. Retirement Systems of Alabama increased its holdings in Stericycle by 0.3% in the first quarter. Retirement Systems of Alabama now owns 116,185 shares of the business services provider’s stock valued at $6,129,000 after purchasing an additional 305 shares during the period. Strategic Blueprint LLC raised its position in Stericycle by 6.2% during the 4th quarter. Strategic Blueprint LLC now owns 5,609 shares of the business services provider’s stock worth $278,000 after purchasing an additional 326 shares during the last quarter. Raymond James Financial Services Advisors Inc. lifted its holdings in Stericycle by 4.9% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 7,243 shares of the business services provider’s stock worth $359,000 after buying an additional 336 shares during the period. Finally, Essex Investment Management Co. LLC grew its position in shares of Stericycle by 16.8% in the 3rd quarter. Essex Investment Management Co. LLC now owns 2,691 shares of the business services provider’s stock valued at $120,000 after buying an additional 387 shares during the last quarter. Institutional investors own 98.82% of the company’s stock.

Stericycle Company Profile

(Get Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

See Also

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.